A Study on the Effect of Etavopivat on Heart Rhythm in Healthy Participants

Clinical trial NCT07023029 · COMPLETED

Trial details

NCT number: NCT07023029
Sponsor: Novo Nordisk A/S
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers Sickle Cell Disease Thalassemia

Start date: 2025-06-09
Primary completion: 2025-09-12
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.